Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy最新文献
Pub Date : 2024-10-01Epub Date: 2024-06-03DOI: 10.1111/1744-9987.14164
Elif Bulbul, Selda Selimoglu Namoglu
Introduction: The aim of this study was to determine the level of frailty in older hemodialysis patients and to examine the relationship between their functional capacity, depression, and laboratory variables.
Method: This was a cross-sectional study, and the data were collected 243 dialysis patients aged 65 and over between May 2021 and May 2022.
Results: The frailty rate was 49%. A statistically significant positive correlation was found between the frailty and age, hemodialysis vintage, and the number of hospitalizations. The frailty was negatively correlated with body mass index, Kt/V, Albumin, and parathyroid hormone. There was a statistically significant positive correlation between frailty and depression and a negative correlation between functional capacity.
Conclusion: A relationship was found between frailty and depression, functional capacity, and laboratory variables. In addition, the variables affecting the level of frailty in geriatric dialysis patients included dialysis vintage, dialysis adequacy, number of hospitalizations, albumin level, and patient weight.
{"title":"The frailty in older hemodialysis patients and associations with depression, functional status, dialysis adequacy.","authors":"Elif Bulbul, Selda Selimoglu Namoglu","doi":"10.1111/1744-9987.14164","DOIUrl":"10.1111/1744-9987.14164","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this study was to determine the level of frailty in older hemodialysis patients and to examine the relationship between their functional capacity, depression, and laboratory variables.</p><p><strong>Method: </strong>This was a cross-sectional study, and the data were collected 243 dialysis patients aged 65 and over between May 2021 and May 2022.</p><p><strong>Results: </strong>The frailty rate was 49%. A statistically significant positive correlation was found between the frailty and age, hemodialysis vintage, and the number of hospitalizations. The frailty was negatively correlated with body mass index, Kt/V, Albumin, and parathyroid hormone. There was a statistically significant positive correlation between frailty and depression and a negative correlation between functional capacity.</p><p><strong>Conclusion: </strong>A relationship was found between frailty and depression, functional capacity, and laboratory variables. In addition, the variables affecting the level of frailty in geriatric dialysis patients included dialysis vintage, dialysis adequacy, number of hospitalizations, albumin level, and patient weight.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"727-734"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141201361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-01Epub Date: 2024-07-16DOI: 10.1111/1744-9987.14187
Shunsuke Kojima, Tatsuya Nakama, Toshihiko Suzuki
{"title":"A case of chronic limb-threatening ischemia treated using Rheocarna via a peripherally inserted central catheter.","authors":"Shunsuke Kojima, Tatsuya Nakama, Toshihiko Suzuki","doi":"10.1111/1744-9987.14187","DOIUrl":"10.1111/1744-9987.14187","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"812-813"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: End-stage renal disease is different from other chronic diseases that the treatment method is as difficult. Our aim in this study was to compare marital adjustment, sexual functions and family functioning between hemodialysis (HD) and peritoneal dialysis (PD) patient.
Method: A total of 21 HD and 27 PD patients were included. Beck Depression Inventory (BDI), Short Form-36 (SF-36), Pittsburgh Sleep Quality Index (PSQI), Arizona Sexual Experiences Scale (ASEX), Golombok-Rust Inventory for Sexual Satisfaction (GRISS), Marital Adjustment Test (MAT) and Family Assessment Device (FAD) were applied.
Results: BDI scores were significantly higher in HD patients (p < 0.001). According to FAD problem solving (p < 0.001), communication (p = 0.00) and general functioning scores (p = 0.04) were higher in PD. The rate of poor sleep quality was 44.4% in the PD group, and 66.7% in HD group (p = 0.12). General health (p = 0.04), vitality (p < 0.001), mental health (p = 0.00) and social functioning (p = 0.00) scores were lower in HD patients.
Conclusion: HD patients are at high risk for psychiatric disorders due to the treatment modality. These patients should be monitored carefully and consultation-liaison services should be increased.
{"title":"Quality of life and sleep, depression, family functioning, and marital adjustment in patients on hemodialysis and peritoneal dialysis.","authors":"Evnur Kahyacı Kılıç, İlhan Kılıç, Yasemin Görgülü, Sedat Üstündağ","doi":"10.1111/1744-9987.14143","DOIUrl":"10.1111/1744-9987.14143","url":null,"abstract":"<p><strong>Introduction: </strong>End-stage renal disease is different from other chronic diseases that the treatment method is as difficult. Our aim in this study was to compare marital adjustment, sexual functions and family functioning between hemodialysis (HD) and peritoneal dialysis (PD) patient.</p><p><strong>Method: </strong>A total of 21 HD and 27 PD patients were included. Beck Depression Inventory (BDI), Short Form-36 (SF-36), Pittsburgh Sleep Quality Index (PSQI), Arizona Sexual Experiences Scale (ASEX), Golombok-Rust Inventory for Sexual Satisfaction (GRISS), Marital Adjustment Test (MAT) and Family Assessment Device (FAD) were applied.</p><p><strong>Results: </strong>BDI scores were significantly higher in HD patients (p < 0.001). According to FAD problem solving (p < 0.001), communication (p = 0.00) and general functioning scores (p = 0.04) were higher in PD. The rate of poor sleep quality was 44.4% in the PD group, and 66.7% in HD group (p = 0.12). General health (p = 0.04), vitality (p < 0.001), mental health (p = 0.00) and social functioning (p = 0.00) scores were lower in HD patients.</p><p><strong>Conclusion: </strong>HD patients are at high risk for psychiatric disorders due to the treatment modality. These patients should be monitored carefully and consultation-liaison services should be increased.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"735-744"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140946785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-01Epub Date: 2024-05-27DOI: 10.1111/1744-9987.14171
Hinpetch Daungsupawong, Viroj Wiwanitkit
{"title":"Active vitamin D analog and SARS-CoV-2 IgG after BNT162b2 vaccination in patients with hemodialysis: Correspondence.","authors":"Hinpetch Daungsupawong, Viroj Wiwanitkit","doi":"10.1111/1744-9987.14171","DOIUrl":"10.1111/1744-9987.14171","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"810-811"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: We focused on neutrophil gelatinase-associated lipocalin (NGAL) and autosomal dominant polycystic kidney disease (ADPKD) progression.
Methods: ADPKD patients with an estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73 m2 were included. Serum NGAL level and NGAL to eGFR ratio (NGR), height-adjusted total kidney volume (hTKV) were assessed initially. Patients were followed-up for 5 years.
Results: Sixty one patients were enrolled and initial eGFR was 73.6 (48.9-101.5) ml/min/1.73m2. EGFR declined by 3.7 mL/min/1.73m2 per year. Thirty four patients (55.7%) exhibited rapid progression. Rapid progression group had lower serum NGAL levels (p < 0.001) and higher hTKV (p < 0.001). Lower serum NGAL level was a risk factor for rapid progression (p < 0.001). NGR was not associated with rapid progression. Serum NGAL level was predictive in for rapid progression ROC analysis (cut-off <10.62 ng/mL).
Conclusion: Relatively lower serum NGAL levels can predict worse outcomes in ADPKD and can provide risk stratification in patients with ADPKD.
{"title":"The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression.","authors":"Cihan Uysal, Sumeyra Koyuncu, Funda Ipekten, Cigdem Karakukcu, Ismail Kocyigit","doi":"10.1111/1744-9987.14163","DOIUrl":"10.1111/1744-9987.14163","url":null,"abstract":"<p><strong>Introduction: </strong>We focused on neutrophil gelatinase-associated lipocalin (NGAL) and autosomal dominant polycystic kidney disease (ADPKD) progression.</p><p><strong>Methods: </strong>ADPKD patients with an estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73 m<sup>2</sup> were included. Serum NGAL level and NGAL to eGFR ratio (NGR), height-adjusted total kidney volume (hTKV) were assessed initially. Patients were followed-up for 5 years.</p><p><strong>Results: </strong>Sixty one patients were enrolled and initial eGFR was 73.6 (48.9-101.5) ml/min/1.73m<sup>2</sup>. EGFR declined by 3.7 mL/min/1.73m<sup>2</sup> per year. Thirty four patients (55.7%) exhibited rapid progression. Rapid progression group had lower serum NGAL levels (p < 0.001) and higher hTKV (p < 0.001). Lower serum NGAL level was a risk factor for rapid progression (p < 0.001). NGR was not associated with rapid progression. Serum NGAL level was predictive in for rapid progression ROC analysis (cut-off <10.62 ng/mL).</p><p><strong>Conclusion: </strong>Relatively lower serum NGAL levels can predict worse outcomes in ADPKD and can provide risk stratification in patients with ADPKD.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"760-768"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141077453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Therapeutic plasma exchange (TPE) is used in a wide spectrum of diseases in critically ill pediatric patients. We aim to review the indications, complications, safety, and outcomes of critically ill children who received TPE.
Methods: All of the TPE procedures performed in a pediatric intensive care unit providing tertiary care during 19 years (January 2013-January 2023) were evaluated retrospectively. A total of 154 patients underwent 486 TPE sessions.
Results: Median age was 6 years (2-12.5) and 35 children had a body weight of <10 kg (22.7%). Number of organ failure was 4 (2-6). Liver diseases were the most common indication for TPE (31.2%) followed by sepsis with multiorgan dysfunction syndrome (27.3%). Overall survival rate was 72.7%. The highest mortality was observed in hemophagocytic lymphohistiocytosis group. Non-survivors had significantly higher number of organ failure (p < 0.001), higher PRISM score (p < 0.001), and higher PELOD score on admission (p < 0.001). Adverse events were observed in 68 (13.9%) sessions. Hypotension (7.8%) and hypocalcemia (5.1%) were the most frequent adverse events.
Conclusion: TPE is safe for critically ill pediatric patients with experienced staff. Survival rate may vary depending on the underlying disease. Survival decreases with the increase in the number of failed organs.
{"title":"Therapeutic plasma exchange in critically ill children: A single center experience.","authors":"Pinar Yazici Özkaya, Gülizar Koç, İrem Ersayoğlu, Kübra Cebeci, Hamiyet Hekimci Özdemir, Nihal Karadas, Deniz Yilmaz Karapinar, Bülent Karapinar","doi":"10.1111/1744-9987.14141","DOIUrl":"10.1111/1744-9987.14141","url":null,"abstract":"<p><strong>Introduction: </strong>Therapeutic plasma exchange (TPE) is used in a wide spectrum of diseases in critically ill pediatric patients. We aim to review the indications, complications, safety, and outcomes of critically ill children who received TPE.</p><p><strong>Methods: </strong>All of the TPE procedures performed in a pediatric intensive care unit providing tertiary care during 19 years (January 2013-January 2023) were evaluated retrospectively. A total of 154 patients underwent 486 TPE sessions.</p><p><strong>Results: </strong>Median age was 6 years (2-12.5) and 35 children had a body weight of <10 kg (22.7%). Number of organ failure was 4 (2-6). Liver diseases were the most common indication for TPE (31.2%) followed by sepsis with multiorgan dysfunction syndrome (27.3%). Overall survival rate was 72.7%. The highest mortality was observed in hemophagocytic lymphohistiocytosis group. Non-survivors had significantly higher number of organ failure (p < 0.001), higher PRISM score (p < 0.001), and higher PELOD score on admission (p < 0.001). Adverse events were observed in 68 (13.9%) sessions. Hypotension (7.8%) and hypocalcemia (5.1%) were the most frequent adverse events.</p><p><strong>Conclusion: </strong>TPE is safe for critically ill pediatric patients with experienced staff. Survival rate may vary depending on the underlying disease. Survival decreases with the increase in the number of failed organs.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"793-801"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140924244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-01Epub Date: 2024-05-31DOI: 10.1111/1744-9987.14165
Yan Guo, Feng Wan, Yan-Peng Shi, Hong-Mei Zhang, Ru-Chun Yang
Introduction: This study was designed to investigate whether renal α-klotho levels are associated with renal pathology. This is the first report on patients with chronic kidney disease (CKD).
Methods: We conducted a retrospective observational study. A total of 65 CKD patients were enrolled. Serum and renal biopsy samples were collected. Estimated glomerular filtration rate (eGFR) was examined by biochemical test. And α-klotho expressions were assessed by RT-PCR and immunohistochemistry. In addition, detailed microscopic findings were reviewed.
Results: Renal α-klotho levels are associated positively with eGFR, and negatively with renal pathology, including interstitial fibrosis, inflammatory cell infiltration, and tubular atrophy.
Conclusions: The renal α-klotho is related to renal pathology.
{"title":"Association between renal α-klotho and renal pathology among patients with chronic kidney disease.","authors":"Yan Guo, Feng Wan, Yan-Peng Shi, Hong-Mei Zhang, Ru-Chun Yang","doi":"10.1111/1744-9987.14165","DOIUrl":"10.1111/1744-9987.14165","url":null,"abstract":"<p><strong>Introduction: </strong>This study was designed to investigate whether renal α-klotho levels are associated with renal pathology. This is the first report on patients with chronic kidney disease (CKD).</p><p><strong>Methods: </strong>We conducted a retrospective observational study. A total of 65 CKD patients were enrolled. Serum and renal biopsy samples were collected. Estimated glomerular filtration rate (eGFR) was examined by biochemical test. And α-klotho expressions were assessed by RT-PCR and immunohistochemistry. In addition, detailed microscopic findings were reviewed.</p><p><strong>Results: </strong>Renal α-klotho levels are associated positively with eGFR, and negatively with renal pathology, including interstitial fibrosis, inflammatory cell infiltration, and tubular atrophy.</p><p><strong>Conclusions: </strong>The renal α-klotho is related to renal pathology.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"769-774"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141181789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-01Epub Date: 2024-07-25DOI: 10.1111/1744-9987.14190
Hajime Nishizawa, Kazuhiro P Izawa, Tsutomu Sakurada
{"title":"Phase angle is related to chronic kidney disease (CKD) stage and physical function in patients with pre-dialysis CKD.","authors":"Hajime Nishizawa, Kazuhiro P Izawa, Tsutomu Sakurada","doi":"10.1111/1744-9987.14190","DOIUrl":"10.1111/1744-9987.14190","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"818-819"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141763688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-01Epub Date: 2024-05-14DOI: 10.1111/1744-9987.14142
Ioannis Kontogiorgos, Panagiotis I Georgianos, Nikolaos C Tsikliras, Kallistheni Leonidou, Vasilios Vaios, Stefanos Roumeliotis, Antonios Karpetas, Konstantia Kantartzi, Stylianos Panagoutsos, Vassilios Liakopoulos
Introduction: Prior observational studies conducted in the hemodialysis population have suggested a reverse association between dialysis-unit blood pressure (BP) and mortality. The present study aimed to investigate the prognostic association of home versus dialysis-unit BP with all-cause mortality in hemodialysis patients.
Methods: At baseline, 146 patients receiving maintenance hemodialysis underwent assessment of their BP with the following methods: (i) 2-week averaged routine predialysis and postdialysis BP measurements; (ii) home BP monitoring for 1 week that included duplicate morning and evening BP measurements with the use of validated devices.
Results: Over a median follow-up period of 38 months (interquartile range [IQR]: 22-54), 44 patients (31.1%) died. In Kaplan-Meier curves, predialysis and postdialysis systolic BP (SBP) was not associated with all-cause mortality, while home SBP appeared to be of prognostic significance (log rank p = 0.029). After stratifying patients into quartiles, all-cause mortality was lowest when home SBP was ranging from 128.1 to 136.8 mmHg (quartile 2). In univariate Cox regression analysis, using quartile 2 as a referent category, the risk of all-cause mortality was 3.32-fold higher in quartile 1, 1.53-fold higher in quartile 3 and 3.25-fold higher in quartile 4. The risk-association remained unchanged after adjustment for several confounding factors (adjusted hazard ratio: 4.79, 1.79, 3.63 for quartiles 1, 3, and 4 of home systolic BP, respectively).
Conclusion: Our findings suggest that among hemodialysis patients, 1-week averaged home SBP is independently associated with all-cause mortality. In sharp contrast, SBP recorded either before or after dialysis over 2 weeks is not prognostically informative.
{"title":"The association of home blood pressure with all-cause mortality in hemodialysis patients: A prospective observational study.","authors":"Ioannis Kontogiorgos, Panagiotis I Georgianos, Nikolaos C Tsikliras, Kallistheni Leonidou, Vasilios Vaios, Stefanos Roumeliotis, Antonios Karpetas, Konstantia Kantartzi, Stylianos Panagoutsos, Vassilios Liakopoulos","doi":"10.1111/1744-9987.14142","DOIUrl":"10.1111/1744-9987.14142","url":null,"abstract":"<p><strong>Introduction: </strong>Prior observational studies conducted in the hemodialysis population have suggested a reverse association between dialysis-unit blood pressure (BP) and mortality. The present study aimed to investigate the prognostic association of home versus dialysis-unit BP with all-cause mortality in hemodialysis patients.</p><p><strong>Methods: </strong>At baseline, 146 patients receiving maintenance hemodialysis underwent assessment of their BP with the following methods: (i) 2-week averaged routine predialysis and postdialysis BP measurements; (ii) home BP monitoring for 1 week that included duplicate morning and evening BP measurements with the use of validated devices.</p><p><strong>Results: </strong>Over a median follow-up period of 38 months (interquartile range [IQR]: 22-54), 44 patients (31.1%) died. In Kaplan-Meier curves, predialysis and postdialysis systolic BP (SBP) was not associated with all-cause mortality, while home SBP appeared to be of prognostic significance (log rank p = 0.029). After stratifying patients into quartiles, all-cause mortality was lowest when home SBP was ranging from 128.1 to 136.8 mmHg (quartile 2). In univariate Cox regression analysis, using quartile 2 as a referent category, the risk of all-cause mortality was 3.32-fold higher in quartile 1, 1.53-fold higher in quartile 3 and 3.25-fold higher in quartile 4. The risk-association remained unchanged after adjustment for several confounding factors (adjusted hazard ratio: 4.79, 1.79, 3.63 for quartiles 1, 3, and 4 of home systolic BP, respectively).</p><p><strong>Conclusion: </strong>Our findings suggest that among hemodialysis patients, 1-week averaged home SBP is independently associated with all-cause mortality. In sharp contrast, SBP recorded either before or after dialysis over 2 weeks is not prognostically informative.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"697-705"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140917525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Pre- to post-dialysis potassium gradient (ΔK) has arrhythmogenic effects; however, its effect on mortality remains unclear. The relationship between ΔK and mortality was assessed.
Methods: All patients undergoing hemodialysis in Beijing in 2014 were eligible for inclusion. The low (≤1.2 mmol/L), median (1.2-1.8 mmol/L), and high (>1.8 mmol/L) ΔK groups were matched by sex, age, diabetes, and dialysis time for enrollmen. The primary and secondary outcomes were all-cause and cardiovascular death within the follow-up. Cox regression analysis was performed to evaluate the effect of ΔK on mortality. We also analyzed the associations of combinations of ΔK and pre-dialysis potassium with mortality.
Results: We enrolled 2181 patients in three matched groups (n = 727 per group). The median follow-up was 72.0 (interquartile range, 53.7-72.0) months. All-cause mortality occurred in 215/727 (29.6%), 95/727 (13.1%), and 198/727 (27.2%) patients in the low-, median-, and high-ΔK groups, respectively. After adjusting for multiple factors, the median ΔK group had better survival than the low- (hazard ratio (HR), 1.91; 95% confidence interval [95% CI], 1.45-2.52; p < 0.001) and high-ΔK groups (HR, 2.17; 95% CI, 1.57-2.99; p < 0.001). Further analysis based on pre-dialysis potassium revealed that when maintaining a level of 4.5-5.5 mmol/L and ΔK of 1.2-1.8 mmol/L, patients had the lowest risk of mortality, whereas the highest risk was observed when pre-dialysis potassium was >5.5 mmol/L and ΔK was >1.8 mmol/L.
Conclusion: Maintaining serum potassium within a appropriate range and reducing potassium fluctuations during dialysis may help to reduce the mortality risk of maintenance hemodialysis patients. These findings provide important data support for the quality control of hemodialysis.
{"title":"Pre- to post-dialysis potassium gradient and mortality in patients on hemodialysis: A propensity-matched analysis.","authors":"Huixian Zhang, Jing Liu, Xu Liu, Wang Guo, Hongdong Huang, Wenhu Liu, Zongli Diao","doi":"10.1111/1744-9987.14213","DOIUrl":"https://doi.org/10.1111/1744-9987.14213","url":null,"abstract":"<p><strong>Introduction: </strong>Pre- to post-dialysis potassium gradient (ΔK) has arrhythmogenic effects; however, its effect on mortality remains unclear. The relationship between ΔK and mortality was assessed.</p><p><strong>Methods: </strong>All patients undergoing hemodialysis in Beijing in 2014 were eligible for inclusion. The low (≤1.2 mmol/L), median (1.2-1.8 mmol/L), and high (>1.8 mmol/L) ΔK groups were matched by sex, age, diabetes, and dialysis time for enrollmen. The primary and secondary outcomes were all-cause and cardiovascular death within the follow-up. Cox regression analysis was performed to evaluate the effect of ΔK on mortality. We also analyzed the associations of combinations of ΔK and pre-dialysis potassium with mortality.</p><p><strong>Results: </strong>We enrolled 2181 patients in three matched groups (n = 727 per group). The median follow-up was 72.0 (interquartile range, 53.7-72.0) months. All-cause mortality occurred in 215/727 (29.6%), 95/727 (13.1%), and 198/727 (27.2%) patients in the low-, median-, and high-ΔK groups, respectively. After adjusting for multiple factors, the median ΔK group had better survival than the low- (hazard ratio (HR), 1.91; 95% confidence interval [95% CI], 1.45-2.52; p < 0.001) and high-ΔK groups (HR, 2.17; 95% CI, 1.57-2.99; p < 0.001). Further analysis based on pre-dialysis potassium revealed that when maintaining a level of 4.5-5.5 mmol/L and ΔK of 1.2-1.8 mmol/L, patients had the lowest risk of mortality, whereas the highest risk was observed when pre-dialysis potassium was >5.5 mmol/L and ΔK was >1.8 mmol/L.</p><p><strong>Conclusion: </strong>Maintaining serum potassium within a appropriate range and reducing potassium fluctuations during dialysis may help to reduce the mortality risk of maintenance hemodialysis patients. These findings provide important data support for the quality control of hemodialysis.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy